voretigene neparvovec Infusion bulk supplier for pharma manufacturers

Voretigene Neparvovec Infusion cells/kg patient Suppliers & Bulk Manufacturers

Available Forms: Subretinal injection

Available Strengths: cells/kg patient

Reference Brands: Luxturna(US & EU)

Voretigene neparvovec (Luxturna) is a gene therapy that delivers a functional RPE65 gene via viral vectors, restoring vision in inherited retinal disease. It improves visual function, enhances light perception, and helps maintain retinal health. Benefits include potential vision stabilization and improved quality of life with a single-dose treatment.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Voretigene Neparvovec Infusion? List it or send an offer →

Product Description:

Voretigene neparvovec (Luxturna) is regulated in the EU and US, supported by dossiers demonstrating safety, efficacy, and manufacturing quality per GMP standards. In the US, FDA approval involved comprehensive clinical trials and validation. In the EU, CE marking certifies conformity with MDR standards for gene therapy applications. These products undergo validation, stability testing, and audits, with detailed documentation including safety profiles, clinical trial data, and manufacturing practices. Ensuring compliance guarantees access to safe, effective gene therapy for inherited retinal diseases, supporting improved vision outcomes and quality of life globally.

Voretigene Neparvovec Infusion — third party manufacturing & bulk supply

Voretigene Neparvovec Infusion cells/kg patient is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Voretigene Neparvovec Infusion is supplied as Subretinal injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Voretigene Neparvovec Infusion listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Voretigene Neparvovec Infusion →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

voretigene neparvovec Infusion is listed as Subretinal injection in cells/kg patient. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

voretigene neparvovec Infusion is referenced against Luxturna(US & EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.